NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 803.00
+17.95 (2.29%)
Oct 19, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 143.83 billion as of October 19, 2026. It is the 8,076th most valuable company in the world and the 491st biggest in India. Its market cap has decreased by 2.81% in one year.
Market Cap
143.83B
Enterprise Value
129.67B
Revenue
34.85B
Global Rank
Country Rank
#491 India
PE Ratio
12.29
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 143.83B, an increase of 33,395.36%. That is a compound annual growth rate of 23.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 143.44B | -11.32% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 317.66B |
| Piramal Pharma | 262.84B |
| Cohance Lifesciences | 177.54B |
| Alivus Life Sciences | 160.73B |
| Eris Lifesciences | 158.77B |
| Alembic Pharmaceuticals | 155.18B |
| Sudeep Pharma | 113.03B |
| Akums Drugs and Pharmaceuticals | 111.99B |